Skin
Product Name |
Application |
Region |
ME024-9p21 |
Tumours, Cutaneous melanoma |
9p21, CDKN2A, CDKNA2B |
P046-TSC2 |
Tuberous Sclerosis |
TSC2 16p13.3 |
P067-PTCH1 |
Gorlin syndrome |
PTCH1 9q22.3 |
P073-IKBKG |
Incontinentia Pigmenti |
Xq28; IKBKG, NEMO, IKBKGP |
P081-NF1 mix 1 |
Neurofibromatosis |
NF1 17q11.2 |
P082-NF1 mix 2 |
Neurofibromatosis |
NF1 17q11.2 |
P092-ABCC6 |
Pseudoxanthoma elasticum |
ABCC6 16p13.11 |
P122-NF1-area |
Neurofibromatosis |
NF1 17q11.2 |
P124-TSC1 |
Tuberous Sclerosis |
TSC1 9q34 |
P160-STS |
Steroid Sulfatase gene (STS) |
STS Xp22 |
P186-PAX3-MITF-SOX10 |
Waardenburg syndrome (WS) type II, WS1, WS3 |
PAX3 2q35, MITF 3p14, SOX10 22q13.1 |
P256-FLCN |
Birt-Hogg-Dube syndrome |
FLCN 17p11, Smith-Magenis syndrome region |
P257-TERT-DKC1 |
Dyskeratosis congenita (DC) |
DKC1 Xq28 |
P289-LMX1B |
Nail patella syndrome (NPS) |
LMX1B 9q33 |
P295-SPRED1 |
SPRED1 |
SPRED1 15q14 |
P325-OCA2 |
oculocutaneous albinism |
OCA2 15q12; TYR 11q14.3 |
P337-TSC2 |
Tuberous sclerosis |
TSC2 gene, 16p13.3 |
P354-KIT SNAI2 |
Piebaldism/KIT |
KIT 4q12, SNAI2 8q11 |
P411-Porphyria mix 1 |
Porphyrias |
ALAD, HMBS, PPOX |
P412-Porphyria mix 2 |
Porphyrias |
FECH, UROS, UROD, CPOX |
P415-COL7A1-KRT5 |
Epidermolysis Bullosa Hereditaria |
3p21.31 COL7A1, 12q13.13 KRT5 |
P416-KRT14-LAMA3-LAMB3-LAMC2 |
Epidermolysis Bullosa Hereditaria |
17q21.2 KRT14; 18q11.2 LAMA3; 1q32.2 LAMB3; 1q25.3 LAMC2 |
P419-CDKN2A/2B-CDK4 |
Familial melanoma |
CDKN2A, CDKN2B, CDK4, MITF E318K |